AnalystsMatthew HarrisonMatthew Harrison's Stock Forecasts
AnalystsMatthew Harrison
Analyst Ranking
Bottom 3%
#4024 out of 4129 analysts
Average Return
-3.03%
Win Rate
47%101 out of 214
Risk vs Reward
Poor
Good
Matthew Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +267.87% | $37.25 | $137.03 | 2020-04-14 - 2020-12-16 | Strong Buy |
Loxo Oncology IncLOXO | +185.28% | $43.47 | $124.01 | 2017-04-02 - 2018-03-21 | Strong Buy |
Denali Therapeutics IncDNLI | +180.06% | $20.01 | $56.04 | 2020-04-14 - 2021-04-15 | Strong Buy |
Forty Seven IncFTSV | +171.94% | $34.66 | $94.24 | 2019-12-09 - 2020-03-03 | Strong Buy |
Atea Pharmaceuticals IncAVIR | +106.33% | $20.53 | $42.36 | 2021-06-02 - 2021-10-05 | Strong Buy |
Matthew Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abbvie IncABBV | 7 | Strong Buy | $182.00 | +11.17% | Maintains | 2 days ago |
Gilead Sciences IncGILD | 16 | Hold | $81.00 | -7.91% | Maintains | 7 days ago |
Editas Medicine IncEDIT | 7 | Strong Sell | $8.00 | -16.75% | Maintains | 20 days ago |
Vigil Neuroscience IncVIGL | 2 | Hold | $12.00 | -2.52% | Maintains | 24 days ago |
Kodiak Sciences IncKOD | 5 | Hold | $9.00 | +23.63% | Maintains | 24 days ago |
Genmab AGMAB | 5 | Strong Sell | $34.00 | -24.93% | Maintains | 24 days ago |
Fulcrum Therapeutics IncFULC | 5 | Strong Buy | $26.00 | +316.00% | Maintains | 24 days ago |
Adc Therapeutics SaADCT | 7 | Hold | $7.00 | +105.28% | Maintains | 24 days ago |
Prime Medicine IncPRME | 1 | Hold | $23.00 | +31.43% | Initiates Coverage On | 24 days ago |
Lyell Immunopharma IncLYEL | 2 | Hold | $7.00 | +78.12% | Downgrades | 24 days ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $55.00 | +183.07% | Maintains | a month ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | $60.00 | +96.98% | Maintains | a month ago |
Biontech SeBNTX | 5 | Hold | $203.00 | +25.60% | Maintains | a month ago |
2seventy Bio IncTSVT | 4 | Strong Buy | $29.00 | +94.24% | Maintains | a month ago |
Galapagos NvGLPG | 13 | Hold | $57.00 | +49.02% | Maintains | a month ago |
Akero Therapeutics IncAKRO | 5 | Hold | $40.00 | -3.71% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 18 | Strong Buy | $868.00 | +16.13% | Maintains | a month ago |
Moderna IncMRNA | 11 | Hold | $170.00 | -2.04% | Maintains | a month ago |
Amgen IncAMGN | 20 | Strong Buy | $282.00 | -0.46% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 7 | Hold | $285.00 | -8.60% | Maintains | a month ago |
Seagen IncSGEN | 11 | Strong Buy | $171.00 | +45.03% | Maintains | a month ago |
Argenx SeARGX | 5 | Strong Buy | $450.00 | +16.72% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 6 | Hold | $210.00 | -4.39% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 12 | Strong Buy | $113.00 | +10.55% | Maintains | a month ago |
Biogen IncBIIB | 20 | Strong Buy | $325.00 | +11.50% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 16 | Hold | $141.00 | +17.40% | Maintains | 2 months ago |
Legend Biotech CorpLEGN | 5 | Strong Buy | $60.00 | +11.19% | Maintains | 2 months ago |
Innoviva IncINVA | 5 | Strong Sell | $14.00 | +6.79% | Maintains | 2 months ago |
Beigene LtdBGNE | 8 | Strong Buy | $295.00 | +57.27% | Maintains | 2 months ago |
Invivyd IncIVVD | 5 | Strong Sell | $3.00 | +53.85% | Maintains | 3 months ago |
Allovir IncALVR | 4 | Strong Buy | $27.00 | +277.62% | Maintains | 3 months ago |
Adagene IncADAG | 4 | Strong Buy | $7.00 | +530.63% | Maintains | 3 months ago |
Alector IncALEC | 3 | Hold | $13.00 | +40.24% | Downgrades | 3 months ago |
Pharvaris NvPHVS | 2 | Hold | $10.00 | +343.46% | Downgrades | 3 months ago |
Cerevel Therapeutics Holdings IncCERE | 3 | Strong Buy | $50.00 | +83.76% | Maintains | 4 months ago |
Vaccitech PLCVACC | 2 | Strong Buy | $16.00 | +595.65% | Maintains | 4 months ago |
Atea Pharmaceuticals IncAVIR | 6 | Strong Sell | $7.00 | +50.21% | Maintains | 4 months ago |
Centessa Pharmaceuticals PLCCNTA | 6 | Strong Sell | $5.00 | +32.98% | Downgrades | 4 months ago |
Insmed IncINSM | 6 | Strong Buy | $41.00 | +116.02% | Maintains | 5 months ago |
Johnson & JohnsonJNJ | 3 | Hold | $173.00 | -1.76% | Maintains | 8 months ago |
Pfizer IncPFE | 4 | Hold | $55.00 | +10.64% | Maintains | 10 months ago |
Bolt Biotherapeutics IncBOLT | 2 | Hold | $11.00 | +691.37% | Downgrades | a year ago |
Sigilon Therapeutics IncSGTX | 3 | Hold | $4.50 | N/A | Maintains | a year ago |
Io Biotech IncIOBT | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Merck & Co IncMRK | 4 | Hold | $82.00 | N/A | Maintains | a year ago |
Bluebird Bio IncBLUE | 11 | Strong Sell | $11.00 | N/A | Downgrades | a year ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 8 | Hold | $145.00 | N/A | Maintains | a year ago |
Kaleido Biosciences IncKLDO | 3 | Strong Sell | $3.00 | N/A | Downgrades | a year ago |
Sage Therapeutics IncSAGE | 3 | Hold | $78.00 | N/A | Maintains | a year ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $66.00 | N/A | Maintains | a year ago |
Tenaya Therapeutics IncTNYA | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | a year ago |
Taysha Gene Therapies IncTSHA | 2 | Strong Buy | $39.00 | N/A | Maintains | a year ago |
Fusion Pharmaceuticals IncFUSN | 2 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Royalty Pharma PLCRPRX | 1 | Hold | $46.00 | N/A | Maintains | a year ago |
Organon & CoOGN | 1 | Hold | $35.00 | N/A | Maintains | a year ago |
Imara IncIMRA | 3 | Hold | $12.00 | N/A | Downgrades | a year ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $275.00 | N/A | Maintains | a year ago |
Grupo Televisa SabTV | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Regenxbio IncRGNX | 4 | Strong Buy | $62.00 | N/A | Maintains | 2 years ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Huntington Bancshares IncHBAN | 1 | Hold | $17.25 | N/A | Maintains | 2 years ago |
Unity Biotechnology IncUBX | 2 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Evelo Biosciences IncEVLO | 1 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Immunomedics IncIMMU | 1 | Hold | $22.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 6 | Hold | $70.00 | N/A | Maintains | 3 years ago |
Alexion Pharmaceuticals IncALXN | 9 | Hold | $116.00 | N/A | Maintains | 3 years ago |
Rubius Therapeutics IncRUBY | 1 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 3 years ago |
Incyte CorpINCY | 1 | Hold | $83.00 | N/A | Maintains | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $83.00 | N/A | Upgrades | 4 years ago |
Celgene CorpCELG | 8 | Hold | $88.00 | N/A | Maintains | 4 years ago |
Radius Health IncRDUS | 4 | Strong Buy | $57.00 | N/A | Maintains | 4 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $32.00 | N/A | Maintains | 4 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 4 years ago |
Cytokinetics IncCYTK | 4 | Hold | $10.00 | N/A | Assumes | 4 years ago |
Bioverativ IncBIVV | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | $43.00 | N/A | Maintains | 5 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.